IL17A and early-onset autosomal dominant Alzheimer disease: Associated KEGG pathways included the specific immune pathway ‘IL-17 signaling (hsa04657)’ and pathways related to tissue damage, such as ‘Pathways of neurodegeneration—multiple diseases (hsa05022)’ and ‘Alzheimer disease (hsa05010)’.